Walgadox-LB Tablet is a combination pharmaceutical formulation containing Doxycycline 100 mg and Lactobacillus 100 million spores, designed to provide effective antibacterial therapy alongside probiotic support. Doxycycline, a broad-spectrum tetracycline antibiotic, inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, thereby preventing the growth and proliferation of susceptible bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and certain sexually transmitted infections. The inclusion of Lactobacillus, a beneficial probiotic, helps maintain and restore the natural balance of gut flora disrupted by antibiotic therapy, reducing the risk of antibiotic-associated diarrhea and other gastrointestinal disturbances. Walgadox-LB Tablet is particularly useful in managing infections where antibiotic-associated dysbiosis is a concern. It should be administered as prescribed by a healthcare professional, with consideration of patient-specific factors such as allergy history and concurrent medications. Caution is advised in pregnant or lactating women and pediatric patients. Common side effects may include gastrointestinal discomfort, nausea, or hypersensitivity reactions. This combination therapy offers a synergistic approach, combining effective antimicrobial action with probiotic benefits to enhance patient outcomes during antibiotic treatment.